Reducing Breathlessness With Dronabinol in COPD Patients
Status:
RECRUITING
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
This clinical trial examines whether Dronabinol, which contains the synthetic psychoactive compound tetrahydrocannabinol (THC), can alleviate severe breathlessness in patients with severe and very severe chronic obstructive pulmonary disease (COPD).
Phase:
PHASE3
Details
Lead Sponsor:
Vejle Hospital
Collaborators:
Odense Patient Data Explorative Network Region of Southern Denmark University of Aarhus University of Southern Denmark